# Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men

> **NCT01104246** · PHASE1 · COMPLETED · sponsor: **Watson Pharmaceuticals** · enrollment: 40 (actual)

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** Testerone Transdermal System

## Key facts

- **NCT ID:** NCT01104246
- **Lead sponsor:** Watson Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01104246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01104246, "Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01104246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*